shutterstock_1022883895_inked_pixels

Inked pixels / Shutterstock.com

23 September 2019AmericasRory O'Neill

Pharma CEO jailed for distributing super-strength drugs

A former pharmaceutical CEO was last Thursday sentenced to 33 months in prison by an Indiana federal court for distributing “adulterated” drugs, including sedatives and opioids which were administered to infants.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

More on this story

More on this story

More features

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

UPC deals further blow to Dexcom in glucose monitor dispute with Abbott

‘A marathon and a sprint at the same time’: How we won $452m damages